
Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced on Wednesday that it has received notification from Nasdaq that KLTO stock has full compliance with all continued listing requirements and will remain listed and traded on the Nasdaq Stock Market
What To Know: Klotho has regained compliance with both the minimum $1.00 bid price and the minimum stockholders’ equity threshold requirements.